Navigation Links
GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting

in the Phase III ADT clinical trial.

-- "Prevalence of osteoporosis and osteopenia during androgen deprivation therapy (ADT) for prostate cancer: Baseline data from a large randomized controlled trial." Poster number: F5. Abstract number: 5116.

-- Date and time: June 3, 2007 from 2:00 to 6:00 p.m.

-- Location: S Hall A2

About GTx

GTx, headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle wasting and other serious medical conditions. GTx is developing ACAPODENE(R) (toremifene citrate), a selective estrogen receptor modulator, or SERM, in two separate clinical programs in men: first, a pivotal Phase III clinical trial for the treatment of serious side effects of androgen deprivation therapy for advanced prostate cancer, and second, a pivotal Phase III clinical trial for the prevention of prostate cancer in high risk men with high grade prostatic intraepithelial neoplasia, or PIN. GTx has licensed to Ipsen Limited exclusive rights in Europe to develop and commercialize ACAPODENE(R). GTx also is developing Ostarine(TM), a first-in-class selective androgen receptor modulator, or SARM. GTx plans to initiate a Phase IIb Ostarine(TM) clinical trial for cancer cachexia in non-small cell lung cancer patients in June of 2007. GTx plans to initiate a Phase IIb Ostarine(TM) clinical trial for the treatment of chronic kidney disease muscle wasting by the end of 2007. GTx believes that Ostarine(TM) also has the potential to treat a variety of other indications associated with muscle wasting and bone loss including sarcopenia and osteoporosis.

Forward-Looking Information is Subject to Risk and Uncertainty

This press release contains forward-looking statements based upon GTx's current expectations. Forward-looking statements involve risks and uncertaint
'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:
(Date:12/2/2009)...December 2 Shire,plc (LS...pharmaceutical,company, announces that it has sett...Inc. ("Teva") over Shire,s supply to Teva of an,au... been supplying Teva with,authorized generic ADDER...ply,the product had been limited by restrictions t...
(Date:12/2/2009)...e-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) tod...st stage of a two-stage pivotal Phase II study eva...ny,s 2009 H1N1 virus-like particle (VLP) pandemic ...dy in collaboration with Avimex Laboratories of Me...ico and potentially other countries. ,, In Stag...
(Date:12/2/2009)...ewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (N...shed the per share amount of the previously announ...re. The dividend will be paid on December 15, 2009...ecember 1, 2009 record date. NASDAQ had previously... dividend at $1.67 per share of common stock for p...
Breaking Medicine Technology:Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 1Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 1American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 3AVMA Survey Indicates Most Starting Salaries Are Up for New Veterinarians 55849 1AVMA Survey Indicates Most Starting Salaries Are Up for New Veterinarians 55849 2AVMA Survey Indicates Most Starting Salaries Are Up for New Veterinarians 55849 3
... MATEO, Calif., April 16 Anthera Pharmaceuticals,...eveloping,anti-inflammatory drugs, announced today...ficacy data currently available, an independent Da...that Anthera,s Phase II clinical,trial, known as t...spholipase in Acute ChesT Syndrome) Study can cont...
... YORK, April 15 Tomorrow Congress will,hold hearin...gh to prevent,deadly hospital infections. The answ...C claims 1.7 million people contract infections in...mes that number. The proof is,in the data., One o...A, which stands,for methicillin-resistant Staphylo...
Other Medicine Technology:DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 2April 16th Congressional Hearing on Hospital Infections 2
(Date:12/2/2009)..., , WASHINGTON, Dec. 2 /PRNewswire-USNews...ton on Wednesday, December 2 in their campaign aga...mendment. ,, Americans United for Life Preside... in response to the abortion lobby,s effort to exp...ing abortion with health care, the feminist groups...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire/ -- The Un...ly) in conjunction with a team of doctors from the...ix-year long research study confirming that Pecori... Linoleic Acid), an Omega-6 polyunsaturated fatty ...hich shows bioactive properties for humans. ,...
(Date:12/2/2009)...udy finds myriad microbes in tobacco, but risk is ... News) -- New research provides evidence that the...ng bacteria that cause respiratory disease. , B...out, the authors of the new study aren,t sure what...acteria is nothing new: Microbes surround us every...
(Date:12/2/2009)..., Fruit flies may seem like unlikely heroes in the...sts that these insects already used to study doze...ists are reporting that fruit flies can be used as...udying the effects of cocaine and other drugs of a...ACS Chemical Neuroscience , a new monthly journal....
(Date:12/2/2009)... ILS Technology and ASML Re... Boca Raton, Fla. (PRWEB) December 2, ... enabling intelligence through connectivity, today...stomer were both recognized with awards for techni...r 7th at ISAexpo, the International Society of Aut...
Breaking Medicine News(10 mins):Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 2Health News:New Study Confirms Health Benefits of Pecorino Romano Cheese 3Health News:Smokers Inhaling Germs With Each Cigarette 2Health News:ILS Technology and Customer ASML Recipients of Industry Recognition Awards 2
...ncourages people affected by diabetes to enter glo...ons and camp scholarships for ... 11 "American Idol" finalist and,rising Hickory R...are of children in developing nations. Yamin, who...
...1,s activity could be valuable, scientists say , T...y associated with longer life span may also be lin...body, say Massachusetts Institute of Technology (M...osclerosis (clogged arteries) and Alzheimer,s dise...
... "Despite continuous,allegations over the years, ... is a naturally occurring element that is found ev... daily to lead when they eat, drink water,and brea..., breathing, and drinking water that meets Environ...
...11 Cardinal Health, Inc.,(NYSE: CAH ), a global ...,safety and productivity of health care, plans to ...on Monday, Nov. 5, prior to the opening of,trading...nd corresponding slide,presentation, go to the Inv...
...---Male sex tourists, largely from the United Stat... in the Caribbean, and efforts to stop the epidemi...dollars are diverted to help male prostitutes, a n...urists and tourism employees, said assistant profe...
....S. Environmental,Protection Agency Region 5 today...request to redesignate Boone, Hamilton, Hancock, H...by counties in central Indiana to,attainment of th...r,2004-2006 shows the area meets the ozone standar...
Other Medicine News:Health News:'American Idol' Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children with Diabetes 2Health News:'American Idol' Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children with Diabetes 3Health News:'American Idol' Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children with Diabetes 4Health News:'American Idol' Finalist and Hickory Records Artist Elliott Yamin to Serve as a Global Ambassador for Inspired by Diabetes Campaign to Help Children with Diabetes 5Health News:Long-Life Gene Might Help Lower Cholesterol 2Health News:Cardinal Health To Announce First-Quarter Results on November 5 2Health News:Lack of HIV prevention for male sex workers in the Caribbean could fuel AIDS epidemic 2
Cytomegalovirus (CMV) IgM EIA
Horizontal Needle Box
Seed Alginment Tray
MT-BT-5051-25 Prostate Seeding Needle
Medicine Products: